BioWorld

Sep. 10, 2004

View Archived Issues

SGX, Roche Partner To Use FAST To Discover Antivirals

Entering the first major pharmaceutical deal for its Fragments of Active Structures drug discovery technology, Structural GenomiX formed an alliance with F. Hoffmann-La Roche Ltd. to discover new antiviral therapeutics. (BioWorld Today) Read More

InKine, FDA Agree On SPA For INKP-102 Phase III Trial

Read More

Transcytosis Research Lending Hope In Long Fight Against HIV

Read More

Push For Public Posting Of Clinical Trial Data Continues

Read More

Graffinity Closes Merger With MyoContract, Forms Santhera

Read More

Other News To Note

Read More

Appointments And Advancements

Read More